News Chart Monte Rosa Therapeutics, Inc.

Stocks

GLUE

US61225M1027

Biotechnology & Medical Research

Market Closed - Nasdaq 02:30:00 14/11/2026 am IST			5-day change	1st Jan Change
9.370 ^USD	+0.64%		-11.35%	-40.24%

10/11	Monte Rosa Therapeutics Presents Preclinical Data On MRT-8102 In Gout	CI
05/11	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

5c3e83fcbc16d58d41fc18d.NvepPL9hormXHjosuuXXljjjp2wvaowhmr1XC_r0i4U.D4PvTvkD-_H2UV5c94KR9Gum0C5_Dt0Yz4U4TKWi-tBdh-x_5RfV9Kcodw~308914a47fc4d081fa542b3cdafbc3eb